Literature DB >> 20053867

Similar favorable outcome of pegfilgrastim overdose in patients with different age and underlying disease.

Carlo Dufour, Barbara Cappelli, Michaela Calvillo, Francesca Fioredda, Rossella Tonelli, Roberto Crocchiolo.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20053867      PMCID： PMC2857202          DOI： 10.3324/haematol.2009.018333

Source DB:  PubMed          Journal:  Haematologica        ISSN： 0390-6078            Impact factor:   9.941


× No keyword cloud information.
  10 in total

1.  Long term results of a randomized study performed by Intergruppo Italiano Linfomi comparing Mini-CEOP vs P-VEBEC in elderly patients with diffuse large B-cell lymphoma.

Authors:  F Merli; M Bertini; S Luminari; R Mozzana; B Botto; A M Liberati; L Baldini; G Cabras; F Di Vito; L Orsucci; E Naglieri; G Polimeno; L Marcheselli; E Pennese; U Vitolo; M Federico; E Gallo
Journal:  Leuk Lymphoma       Date:  2007-02

2.  Respiratory distress and sudden death of a patient with GSDIb chronic neutropenia: possible role of pegfilgrastim.

Authors:  Jean Donadieu; Blandine Beaupain; Frédérique Rety-Jacob; Raphaelle Nove-Josserand
Journal:  Haematologica       Date:  2009-08       Impact factor: 9.941

3.  A randomized double-blind multicenter phase III study of fixed-dose single-administration pegfilgrastim versus daily filgrastim in patients receiving myelosuppressive chemotherapy.

Authors:  M D Green; H Koelbl; J Baselga; A Galid; V Guillem; P Gascon; S Siena; R I Lalisang; H Samonigg; M R Clemens; V Zani; B C Liang; J Renwick; M J Piccart
Journal:  Ann Oncol       Date:  2003-01       Impact factor: 32.976

Review 4.  Functional features of neutrophils induced by G-CSF and GM-CSF treatment: differential effects and clinical implications.

Authors:  K Spiekermann; J Roesler; A Emmendoerffer; J Elsner; K Welte
Journal:  Leukemia       Date:  1997-04       Impact factor: 11.528

5.  Comparable efficacy and safety profiles of once-per-cycle pegfilgrastim and daily injection filgrastim in chemotherapy-induced neutropenia: a multicenter dose-finding study in women with breast cancer.

Authors:  F A Holmes; S E Jones; J O'Shaughnessy; S Vukelja; T George; M Savin; D Richards; J Glaspy; L Meza; G Cohen; M Dhami; D R Budman; J Hackett; M Brassard; B B Yang; B C Liang
Journal:  Ann Oncol       Date:  2002-06       Impact factor: 32.976

6.  Is pegfilgrastim safe and effective in congenital neutropenia? An analysis of the French Severe Chronic Neutropenia registry.

Authors:  Blandine Beaupain; Thierry Leblanc; Oumédaly Reman; Olivier Hermine; Jean-Pierre Vannier; Felipe Suarez; Patrick Lutz; Pierre Bordigoni; Anne Jourdain; Michele Schoenvald; Marie Ouachee; Sylvie François; Fréderic Kohser; Fabrice Jardin; Gilles Devouassoux; Yves Bertrand; Raphaele Nove-Josserand; Jean Donadieu
Journal:  Pediatr Blood Cancer       Date:  2009-12       Impact factor: 3.167

7.  Pegfilgrastim in children with severe congenital neutropenia.

Authors:  Francesca Fioredda; Michaela Calvillo; Marina Lanciotti; Tiziana Lanza; Laura Giunti; Elio Castagnola; Ines Lorenzi; Rossella Tonelli; Piero Ghezzi; Carlo Dufour
Journal:  Pediatr Blood Cancer       Date:  2010-03       Impact factor: 3.167

8.  Serum pegfilgrastim concentrations during recovery of absolute neutrophil count in patients with cancer receiving pegfilgrastim after chemotherapy.

Authors:  Bing-Bing Yang; Anna Kido; Atsuko Shibata
Journal:  Pharmacotherapy       Date:  2007-10       Impact factor: 4.705

9.  Pegylated granulocyte colony-stimulating factor mobilizes CD34+ cells with different stem and progenitor subsets and distinct functional properties in comparison with unconjugated granulocyte colony-stimulating factor.

Authors:  Ingmar Bruns; Ulrich Steidl; Johannes C Fischer; Akos Czibere; Guido Kobbe; Sascha Raschke; Raminder Singh; Roland Fenk; Michael Rosskopf; Sabrina Pechtel; Arndt von Haeseler; Peter Wernet; Daniel G Tenen; Rainer Haas; Ralf Kronenwett
Journal:  Haematologica       Date:  2008-02-11       Impact factor: 9.941

10.  Impairment in gas exchange after granulocyte colony stimulating factor (G-CSF) in a patient with the adult respiratory distress syndrome.

Authors:  G J Schilero; J Oropello; E Benjamin
Journal:  Chest       Date:  1995-01       Impact factor: 9.410
  10 in total
  1 in total

1.  Overdose of pegfilgrastim: case report.

Authors:  Gisela Riu; Anna Estefanell; Meritxell Nomdedeu; Natàlia Creus
Journal:  Int J Clin Pharm       Date:  2012-07-21
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.